Medication info
Atorren Tablets 10 mg (Atorvastatin Calcium Trihydrate)

Atorren Tablets 10 mg (Atorvastatin Calcium Trihydrate)

Prescription medicationTabletOral
Ingredient · strength
Atorvastatin Calcium Trihydrate›10.85mg / 1 tablet
Manufacturer / importer
Withus Pharmaceutical Co., Ltd.
Appearance
White round film-coated tablet
Packaging
Domestic - 30 tablets/bottle, Domestic - 100 tablets/bottle, Export - 30 tablets/box [10 tablets/PTP x 3]
Approval status
Active

MFDS item code 200709794 · Notified 2007.08.24 · Insurance code 660700860

Summary

Main use
Improvement of hyperlipidemia and prevention of cardiovascular diseases (myocardial infarction, stroke, etc.)
Who takes it
Adults · Children
Adult dose
Patients receiving atorvastatin should follow a standard cholesterol-lowering diet before and during treatment. The medication may be taken at any time of day, with or without food. 1. Hyperlipidemia The recommended initial dose is 10 mg of atorvastatin once daily. However, patients requiring a greater reduction in LDL cholesterol may start at 20 mg or 40 mg once daily (40 mg is for patients requiring an LDL cholesterol reduction of 45 % or more). This medication is administered once daily at doses ranging from 10 ~ 80 mg. The initial and maintenance doses should be individualized according to the patient's characteristics, taking into account treatment goals and response. Lipid levels should be analyzed within 2 ~ 4 weeks after starting treatment and/or adjusting the dose, and the dose should be adjusted accordingly. Because the goal of treatment is to lower LDL cholesterol, LDL cholesterol is recommended for use when initiating treatment and evaluating response. However, if LDL cholesterol levels are unavailable, total cholesterol levels should be used to monitor treatment response. Patients with homozygous familial hypercholesterolemia The dose is 10 ~ 80 mg once daily. This medication is administered in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such treatments are not possible. ○ Patients with renal impairment: Renal disease does not affect plasma concentrations of atorvastatin or its LDL cholesterol-lowering effect; therefore, dose adjustment is not necessary. ○ Older adults: Efficacy and safety in patients aged 70 years and older are similar to those in the general adult patient population.
Child dose
Ages 10 ~ 17: 10 mg once daily, up to a maximum of 20 mg daily

Ingredients

Manufacturer
Withus Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of hyperlipidemia and prevention of cardiovascular diseases (myocardial infarction, stroke, etc.)

  • Coronary heart disease
  • myocardial infarction
  • stroke
  • vascular interventions
  • chronic stable angina
  • retinopathy
  • albuminuria
  • hypertension
  • type 2 diabetes
  • congestive heart failure
  • angina
  • hyperlipidemia
View approved original text

This medication is used to reduce the risk of cardiovascular diseases. For example, it lowers the risk of myocardial infarction and stroke in adult patients with risk factors for coronary heart disease, and it also reduces the risk of vascular interventions and chronic stable angina. In particular, it helps to reduce the risk of myocardial infarction and stroke in patients with type 2 diabetes. In patients with clinical evidence, it is effective in reducing the risk of non-fatal myocardial infarction, fatal and non-fatal stroke, vascular interventions, and congestive heart failure hospitalizations. Additionally, it acts as an adjunct to diet in patients with hyperlipidemia by decreasing total cholesterol, LDL cholesterol, and triglyceride levels, and increasing HDL cholesterol levels. It is also used to improve blood lipid levels in pediatric patients with heterozygous familial hypercholesterolemia.

How to take

Adult dose

Patients receiving atorvastatin should follow a standard cholesterol-lowering diet before and during treatment. The medication may be taken at any time of day, with or without food. 1. Hyperlipidemia The recommended initial dose is 10 mg of atorvastatin once daily. However, patients requiring a greater reduction in LDL cholesterol may start at 20 mg or 40 mg once daily (40 mg is for patients requiring an LDL cholesterol reduction of 45 % or more). This medication is administered once daily at doses ranging from 10 ~ 80 mg. The initial and maintenance doses should be individualized according to the patient's characteristics, taking into account treatment goals and response. Lipid levels should be analyzed within 2 ~ 4 weeks after starting treatment and/or adjusting the dose, and the dose should be adjusted accordingly. Because the goal of treatment is to lower LDL cholesterol, LDL cholesterol is recommended for use when initiating treatment and evaluating response. However, if LDL cholesterol levels are unavailable, total cholesterol levels should be used to monitor treatment response. Patients with homozygous familial hypercholesterolemia The dose is 10 ~ 80 mg once daily. This medication is administered in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such treatments are not possible. ○ Patients with renal impairment: Renal disease does not affect plasma concentrations of atorvastatin or its LDL cholesterol-lowering effect; therefore, dose adjustment is not necessary. ○ Older adults: Efficacy and safety in patients aged 70 years and older are similar to those in the general adult patient population.

Child dose

Ages 10 ~ 17: 10 mg once daily, up to a maximum of 20 mg daily

Precautions

This medication may cause muscle-related symptoms, so if there is muscle pain or weakness, you should discontinue use immediately and consult a doctor. This medication may affect liver function; therefore, it should not be administered to patients with liver diseases or elevated liver enzymes, and liver function tests should be performed regularly. Women who are pregnant, may become pregnant, or are breastfeeding should not take this medication. It should not be used in children, especially those under 10 years of age, and the long-term safety in pediatric patients under 18 years has not been established. This medication may interact with certain drugs, so if you are currently taking any medications, you must inform your doctor or pharmacist. Patients with severe kidney disease or myopathy are at increased risk for muscle-related adverse reactions while taking this medication, so caution is needed. If you experience sudden muscle pain, muscle cramps, weakness, or fever while taking this medication, inform your doctor immediately and get tested. When taken with grapefruit juice or certain antibiotics and antifungals, this medication may have increased blood concentration, raising the risk of side effects, thus caution is advised. Also, this medication contains lactose, so patients with lactose intolerance should check before taking it. When storing this medication, keep it out of reach of children and store it in its original container to maintain quality.

Side effects

  • Apathy
  • lethargy
  • chest pain
  • peripheral edema
  • fatigue
  • fever
  • rhinitis
  • hyperglycemia
  • hypoglycemia
  • weight gain
Show 172 more
  • loss of appetite
  • constipation
  • abdominal distention
  • dyspepsia
  • nausea
  • diarrhea
  • abdominal pain
  • vomiting
  • belching
  • pancreatitis
  • pharyngodynia
  • laryngodynia
  • epistaxis
  • insomnia
  • nightmares
  • headache
  • dizziness
  • paresthesia
  • sensory decline
  • dysgeusia
  • memory loss
  • peripheral neuropathy
  • myalgia
  • arthritis
  • limb pain
  • musculoskeletal pain
  • muscle cramps
  • joint swelling
  • back pain
  • neck pain
  • muscle fatigue
  • rupture-related complications
  • myopathy
  • myositis
  • rhabdomyolysis
  • tendon disorders
  • muscle rupture
  • lupus-like syndrome
  • immune-mediated necrotizing myopathy
  • thrombocytopenia
  • vasculitis
  • allergic reactions
  • anaphylaxis
  • hepatitis
  • cholestasis
  • liver failure
  • blurred vision
  • visual impairment
  • tinnitus
  • hearing loss
  • urticaria
  • skin rashes
  • itching
  • hair loss
  • angioedema
  • neurogenic edema
  • erythema multiforme
  • blistering dermatitis
  • Stevens-Johnson syndrome
  • toxic epidermal necrolysis
  • gynecomastia
  • abnormal liver function tests
  • increased serum CK
  • positive urinary leukocytes
  • vomiting
  • abdominal abnormalities
  • hepatitis
  • cholestasis
  • cholestatic jaundice
  • abnormal liver function test results
  • gastroenteritis
  • enteritis
  • dry mouth
  • rectal bleeding
  • esophagitis
  • belching
  • glossitis
  • oral ulcers
  • stomatitis
  • cholecystalgia
  • cheilitis
  • gastric duodenal ulcer
  • dysphagia
  • melena
  • gingival bleeding
  • postprandial urgency
  • bronchitis
  • rhinitis
  • pneumonia
  • dyspnea
  • asthma
  • sensory disturbances
  • vertigo
  • phototoxic reactions
  • drowsiness
  • forgetfulness
  • abnormal dreams
  • decreased libido
  • emotional instability
  • ataxia
  • torticollis
  • facial paralysis
  • hyperkinesia
  • depression
  • increased tension
  • myositis
  • muscle diseases
  • arthritis
  • bursitis
  • tenosynovitis
  • myasthenia gravis
  • tendon contracture
  • elevated serum myoglobin
  • contact dermatitis
  • dry skin
  • sweating
  • acne
  • eczema
  • seborrhea
  • skin ulcer
  • erectile dysfunction
  • urinary tract infection
  • frequent urination
  • cystitis
  • hematuria
  • dysuria
  • kidney stones
  • nocturia
  • epididymitis
  • breast fibrocystic changes
  • vaginal bleeding
  • albuminuria
  • breast enlargement
  • cervical secretions
  • nephritis
  • urinary incontinence
  • urinary retention
  • urgency
  • abnormal ejaculation
  • uterine bleeding
  • discoloration of urine
  • hypoglycemia
  • hyperglycemia
  • increased appetite
  • vascular neurogenic edema
  • chest pain
  • angina pectoris
  • facial swelling
  • fever
  • neck stiffness
  • generalized edema
  • amblyopia
  • dry eyes
  • refractive errors
  • ocular hemorrhage
  • hearing loss
  • glaucoma
  • graft rejection
  • loss of taste
  • dysgeusia
  • leukopenia
  • anemia
  • decreased testosterone
  • increased cholinesterase
  • elevated TSH
  • elevated ACTH
  • decreased aldosterone
  • increased potassium
  • elevated BUN
  • cerebral infarction
  • palpitations
  • tachycardia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to avoid contact with air or moisture. It is also recommended to keep the medication in a cool room temperature, between 1 and 30 degrees Celsius.

Appearance and packaging

Appearance

White round film-coated tablet

Package unit

Domestic - 30 tablets/bottle, Domestic - 100 tablets/bottle, Export - 30 tablets/box [10 tablets/PTP x 3]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.